首页>
美国卫生研究院文献>The Oncologist
>Phase II Study of Modified Carboplatin Plus Weekly Nab‐Paclitaxel in Elderly Patients with Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
【2h】
Phase II Study of Modified Carboplatin Plus Weekly Nab‐Paclitaxel in Elderly Patients with Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
机译：改良的卡铂联合纳布紫杉醇每周治疗老年非小细胞肺癌的II期研究：北日本肺癌研究组试验1301
- 摘要
- 著录项
- 相似文献
- 相关主题
摘要
Lessons Learned. class="unordered" style="list-style-type:disc" id="onco12154-list-0002">Weekly nanoparticle albumin‐bound‐paclitaxel (75 mg/m2) in combination with carboplatin (area under the curve 6 mg/mL/min) in elderly patients with previously untreated, advanced non‐small cell lung cancer showed favorable efficacy, was well tolerated, and showed less neuropathic toxicity. This modified regimen offers potential for the treatment of elderly patients.
机译：得到教训。 class =“ unordered” style =“ list-style-type：disc” id =“ onco12154-list-0002”> <！-list-behavior = unordered prefix-word = mark-type = disc max-label- size = 0-> 每周纳米颗粒白蛋白结合紫杉醇（75 mg / m 2 ）与卡铂组合（曲线下面积6 mg） / mL / min）对先前未经治疗的晚期非小细胞肺癌的老年患者显示出良好的疗效，耐受性良好且神经病理毒性较小。 此改良的治疗方案为老年患者的治疗提供了潜力。
著录项
- 期刊名称 The Oncologist
-
作者单位
- 年(卷),期 2017(22),6
- 年度 2017
- 页码 640–e59
- 总页数 5
- 原文格式 PDF
- 正文语种
- 中图分类 肿瘤学;
-
关键词
相似文献
- 外文文献
- 中文文献
- 专利
-
1. Phase II Study of Modified Carboplatin Plus Weekly Naba??Paclitaxel in Elderly Patients with Nona??Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301 [J] . Eisaku Miyauchi, Akira Inoue, Kazuhiro Usui, The oncologist . 2017,第6期
机译：改良的卡铂联合每周Naba紫杉醇治疗9例老年娜娜小细胞肺癌患者的研究：北日本肺癌研究组试验1301
-
2. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301 [J] . Miyauchi Eisaku, Inoue Akira, Usui Kazuhiro, The oncologist . 2017,第6期
机译：DEARIED CARBOPLATIN PLUS的II期研究加上老年非小细胞肺癌患者的NAB-PABLITAXEL：北日本肺癌研究组试验1301
-
3. PHASE II STUDY OF CARBOPLATIN (CBDCA) PLUS WEEKLY NAB-PACLITAXEL (NAB-PTX) IN ELDERLY PATIENTS (PTS) WITH NON-SMALL CELL LUNG CANCER (NSCLC): NORTH JAPAN LUNG CANCER STUDY GROUP TRIAL 1301 [J] . Morikawa Naoto, Sugawara Shunichi, Miyauchi Eisaku, Respirology : . 2015,第Suppla3期
机译：非小细胞肺癌（NSCLC）老年患者（PTS）中碳素蛋白（CBDCA）加上每周NAB-PACXITAXEL（NAB-PTX）的第二阶段研究：北日本肺癌研究组试验1301
-
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009
机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
-
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012
机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
-
6. Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801 [O] . Makoto Maemondo, Akira Inoue, Shunichi Sugawara, 2014
机译：比较卡铂联合每周紫杉醇和多西他赛治疗老年晚期非小细胞肺癌老年患者的随机第二阶段试验：北日本肺癌组试验0801
-
7. Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study [O] . Isamu Okamoto, Kazuko Sakai, Satoshi Morita, 2014
机译：非小细胞肺癌的多重基因组分析来自第一线S-1 / Carboplatin的次阶段III试验与PACLitaxel / carboplatin：西日本肿瘤学群体研究结果
代理获取
